Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS ‐ CoV ‐2 Infection
The FASEB Journal · 2025
DOI: 10.1096/fj.202403195r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jeffrey A Tomalka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Leukocytes, Mononuclear, DNA Damage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR), NIGMS NIH HHS.
Abstract (Originalsprache)
Many questions remain unanswered regarding the implication of genetics and lipid metabolites with severe SARS‐CoV‐2 infections. We performed bulk RNA‐seq and a total fatty acid panel analysis on PBMCs and plasma collected from 10 infected and 10 uninfected patients. Univariate comparison of lipid metabolites using the Mann–Whitney U ‐test revealed that six lipid metabolites were significantly increased in COVID‐19 patients, including the lipid mediators arachidonic acid (AA) and eicosapentaenoic acid (EPA), which both give rise to eicosanoids. Key lipids implicated in inflammation, including AA and EPA, along with the fatty acids DHA and DPA, were significantly and positively correlated to the WHO disease severity score. Analysis of our bulk RNA‐seq dataset demonstrated distinct transcriptional profiles leading to a segregation of COVID‐19 patients based on the WHO score. Ontology, KEGG, and Reactome analysis identified several key pathways and nodes that were enriched for genes related to innate immunity, interactions between lymphoid and nonlymphoid cells, interleukin signaling, and subsequent DNA damage pathways. EPA levels correlated with heightened cell cycling and DNA damage pathways observed in patients with a high WHO score. We studied gene expression in nasopharyngeal swabs from 58 healthy and COVID‐19 participants and identified that genes implicated in eicosanoid synthesis, such as alox5, alox12, and alox15B, were specifically up‐regulated in high WHO score patients in several cell types of the nasopharynx, especially goblet cells across different viral variants (Deta and Omicron). Using published nasal scRNA‐seq datasets from COVID‐19 patients, we evaluated the expression of genes implicated in eicosanoid synthesis, such as ALOX5 , ALOX15, and ALOX15B , across nasal cell types and COVID‐19 severity groups. Altogether, our study highlights the fact that the increase in specific lipids implicated in inflammation and the genes required for their synthesis correlated with the severity of the SARS‐CoV‐2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
- Department of Medicine, Section of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
- Program in Health Sciences & Technology, Harvard Medical School & MIT, Boston, Massachusetts, USA.
- Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Förderung
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR)
- NIGMS NIH HHS
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institute of General Medical Sciences
Zitieren
APA
Tomalka, J. A., Owings, A., Galeas-Pena, M., Ziegler, C. G. K., Robinson, T. O., Wichman, T. G., Laird, H., Williams, H. B., Ghaliwal, N. S., Everman, S., Zafar, Y., Walsh, J. M. L., Shalek, A. K., Horwitz, B. H., Ordovas-Montanes, J., Glover, S. C., & Gibert, Y. (2025). Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS ‐ CoV ‐2 Infection. The FASEB Journal. https://doi.org/10.1096/fj.202403195r
Vancouver
Tomalka JA, Owings A, Galeas-Pena M, Ziegler CGK, Robinson TO, Wichman TG, et al. Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS ‐ CoV ‐2 Infection. The FASEB Journal. 2025. doi:10.1096/fj.202403195r
BibTeX
@article{Tomalka2025,
author = {Tomalka, Jeffrey A and Owings, Anna and Galeas-Pena, Michelle and Ziegler, Carly G K and Robinson, Tanya O and Wichman, Thomas G and Laird, Hannah and Williams, Haley B and Ghaliwal, Neha S and Everman, Steven and Zafar, Yousaf and Walsh, Jaclyn M L and Shalek, Alex K and Horwitz, Bruce H and Ordovas-Montanes, Jose and Glover, Sarah C and Gibert, Yann},
title = {Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS ‐ CoV ‐2 Infection},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403195r}
}
EUVIMED